(((S)-5-Amino-1-carboxypentyl)carbamoyl)-L-glutamic acid

Catalog No. :
ACPYEW270
CAS No. :
1025796-32-0
Molecular Formula :
C12H21N3O7
Molecular Weight :
319.31

IUPAC Name:(((S)-5-amino-1-carboxypentyl)carbamoyl)-L-glutamic acid

(((S)-5-Amino-1-carboxypentyl)carbamoyl)-L-glutamic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$136.00Login to see priceIn stockInquiry
100mg95%$230.00Login to see priceIn stockInquiry
250mg95%$436.00Login to see priceIn stockInquiry
1g95%$1475.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(((S)-5-Amino-1-carboxypentyl)carbamoyl)-L-glutamic acid
IUPAC Name(((S)-5-amino-1-carboxypentyl)carbamoyl)-L-glutamic acid
MDL No.-
Molecular FormulaC12H21N3O7
Molecular Weight319.31
SMILESO=C(O)[C@@H](NC(N[C@H](C(O)=O)CCCCN)=O)CCC(O)=O
InChI KeyZZASEPMMGWJWOV-YUMQZZPRSA-N
Synonym(S,S)-2-[3-(5-amino-1-carboxy-pentyl)-ureido]-pentanedioic acid;L-Glutamic acid, N-[[[(1S)-5-amino-1-carboxypentyl]amino]carbonyl]-;(S)?-?2-?(3-?((S)?-?5-?amino-?1-?carboxypentyl)?ureido)?pentanedioic acid;GCPII-IN-1;Lys-Urea-Glu
CAS No.1025796-32-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACPYEW270 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHXFI180 route compound structure diagram
    ACHXFI1801025796-31-9 In Stock
  2. Then
  3. ACPYEW270 route product structure diagram
    ACPYEW2701025796-32-0 In Stock
Inquiry

2. ACPYEW270 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYEW270 route product structure diagram
    ACPYEW2701025796-32-0 In Stock
Inquiry

Comments (0)